Okuda T,Higashide T,Wakabayashi Y,et al.Fundus autofluorescence and spectral-domain optical coherencetomography findings of leopard spots in nanophthalmic uvealeffusion syndrome[J].Graefes Arch Clin Exp Ophthalmol,2010,248(8):1 199-1 202.
[2]
吴蝉,董方田,陈有信,等.葡萄膜渗漏综合征的临床特征和治疗效果[J].中华实验眼科杂志,2012,30(9):811-814.Wu C,Dong FT,Chen YX,et al.Clinical feature and management of uveal effusion syndrome[J].Chin JExp Ophthalmol,2012,30(9):811-814.
[3]
Sabrosa NA,Smith HB,MacLaren RE.Scleral punch method with topical mitomycin C for safe revision of failed deep sclerectomy in nanophthalmic uveal effusion syndrome[J].Graefes Arch Clin Exp Ophthalmol,2009,247(7):999-1 001.
[4]
Lee JH,Choi JY,Kim SS.Two cases of uveal effusion syndrome[J].Korean J Ophthalmol,2006,20(2):124-127.
[5]
Suzuki Y,Nishina S,Azuma N.Scleral window surgery and topical mitomycin C for nanophthalmic uveal effusion complicated by renal failure:case report[J].Graefes Arch Clin Exp Ophthalmol,2007,245(5):755-757.
Jackson TL,Hussain A,Salisbury J,et al.Transscleral albumin diffusion and suprachoroidal albuminconcentration in uveal effusion syndrome[J].Retina,2012,32(1):177-182.
[8]
Uyama M,Takahashi K,Kozaki J,et al.Uveal effusion syndrome:clinical features,surgical treatment,histologic examination of the sclera,and pathophysiology[J].Ophthalmology,2000,107(3):441-449.
